Sanofi has reported net sales of $10.32bn (€8.7bn) in the second quarter (Q2) of 2021, a surge of 6.5% on…
30 Jul 2021
FDA expands EUA for Lilly-Incyte’s baricitinib as Covid-19 monotherapy
The US Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for Eli Lilly and Incyte’s drug, baricitinib, for Covid-19 treatment with or without remdesivir. Discovered by…
29 Jul 2021
Pfizer records 92% growth in Q2 2021 revenue
Pfizer has reported a 92% increase in revenue to $19bn in the second quarter (Q2) of 2021, compared to $9.86bn in the Q2 last year. The operational rise in revenue…
29 Jul 2021
GSK and Vir enter supply deal with European Commission for Covid-19 drug
GlaxoSmithKline (GSK) and Vir Biotechnology have entered a joint procurement agreement with the European Commission (EC) to deliver up to 220,000 doses of the companies’ experimental drug, sotrovimab, to treat…
27 Jul 2021
FDA approves GSK’s shingles vaccine for immunocompromised adults
The US Food and Drug Administration (FDA) has approved GlaxoSmithKline’s (GSK) adjuvanted Zoster vaccine recombinant, Shingrix, to prevent herpes zoster (shingles) in immunocompromised people aged 18 years and above. Shingrix…
26 Jul 2021
US acquires 200 million more doses of Pfizer-BioNTech’s Covid-19 vaccine
The US Government has bought an additional 200 million doses of Pfizer and BioNTech’s Covid-19 vaccine for meeting the continued requirement for jabs in the country. The vaccine is authorised…
26 Jul 2021
FDA approves AstraZeneca’s Bydureon BCise for paediatric type 2 diabetes
The US Food and Drug Administration (FDA) has approved AstraZeneca’s Bydureon BCise (exenatide extended-release) to enhance glycaemic control in paediatric patients aged ten to 17 years with type 2 diabetes…
© Copyright Verdict Media Limited 2021
Powered by
